Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Therapeutic and Diagnostic Pearls

Description

In this session, a clinician shares key insights from diverse patient cases, highlighting diagnostic and therapeutic pearls. A notable case involves a 67-year-old man diagnosed with cutaneous sarcoidosis after presenting with skin discoloration. Treatment initially included topical tacrolimus and hydroxychloroquine, later augmented with a TNF inhibitor and narrowband UVB therapy, resulting in significant skin improvement over two years. Another case featured a 25-year-old man with acne complicated by pityrosporum folliculitis, treated with a combination of topical retinoids, benzoyl peroxide, antibiotics, and fluconazole, demonstrating the importance of targeting multiple factors in chronic skin conditions. A third case showcased a woman with hyperpigmented patches, correctly identified as lichen planus pigmentosis rather than melasma due to distinctive color variations, leading to tailored treatment approaches, including low-dose isotretinoin and laser therapies. The speaker emphasized the challenge and necessity of addressing post-inflammatory hyperpigmentation, particularly following psoriasis, illustrating successful treatments with combination therapies that led to marked improvements. The session concluded by discussing early signs of central centrifugal cicatricial alopecia (CCCA), where localized hair breakage may indicate onset. Dermatoscopic features, especially grayish-white halos, serve as vital diagnostic clues, allowing for timely intervention to preserve hair follicles. Overall, the emphasis was on the importance of accurate diagnosis, multifaceted treatment strategies, and proactive patient management.

View more

Conclusions

  • Combination therapies are effective in managing refractory cutaneous sarcoidosis, with TNF inhibitors showing significant outcome improvements.
  • Effective acne treatment involves addressing both the acne and associated post-inflammatory hyperpigmentation (PIH) with combined topical and systemic therapies.
  • Facial hyperpigmented patches require differential diagnosis to rule out conditions beyond melasma, including lichen planus pigmentosus and drug reactions.
  • Identification of early signs, such as hair breakage and specific dermatoscopic features, can facilitate timely intervention for conditions like central centrifugal cicatricial alopecia (CCCA).
  • Oral isotretinoin and laser therapy are beneficial for treating stubborn forms of hyperpigmentation, ensuring safety and efficacy with careful monitoring.
  • An extensive treatment regimen incorporating topical agents, systemic therapies, and procedural modalities can lead to significant progress in resolving chronic hyperpigmentation issues.
  • Dai C et al. Am J Clin Dermatol. 2019. Published online: 20 March 2019; 20:409-422.
  • Dlova NC. Br J Dermatol. 2013 Feb;168(2):439-42.
  • Syder N, Sicco K, Gutierrez D. J Drugs Dermatol. 2022 Mar 1;21(3):324-330.
  • Donkor, C.M.Y.A ., Aryee-Boi, J ., Osazuwa, I.R ., Afflu, F.K ., Alexis, A.F ., Ansah-Addo, S. (2021). Hair Disorders. In: Atlas of Dermatological Conditions in Populations of African Ancestry. Springer.
  • Callender VD, Wright DR, Davis EC, Sperling LC. Arch Dermatol. 2012 Sep;148(9):1047.
  • Miteva M, Tosti A. J Am Acad Dermatol 2014;71:443-9.
  • Lawson CN, Bakayoko A, Callender VD Dermatol Clin. 2021 Jul;39(3):389.